Nevertheless, procalcitonin adds crucial information to the decision-making process; Esposito et al. showed that PCT-based protocol might decrease the use of antibiotics in pneumonia by approximately 15% [36], not only reducing the number of patients who receive antibiotics but also shortening the duration of antibiotic administration without any harm to the patients. The gene discussed is CALCA; the disease is pneumonia.